6640--LAB - CEPHEID MRSA PCR MOLECULAR TESTING
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (DVA) Network Contracting Office NCO2 intends to award a Firm Fixed Price (FFP) sole source contract to Cepheid Inc. for PCR Molecular Diagnostic testing services. This requirement covers the continued use and maintenance of Cepheid GeneXpert and Infinity instruments, along with the supply of necessary reagents, controls, and consumables for various VA Medical Centers in VISN2 South. Capability statements from responsible sources are due by May 22, 2026.
Scope of Work
This opportunity is for the continued provision of Polymerase Chain Reaction (PCR) Molecular Diagnostic testing on a cost-per-reportable/test basis. It includes the use of government-owned and contractor-provided Cepheid GeneXpert and Infinity instruments, their maintenance, and the supply of reagents, controls, consumables, and supplementary items. The comprehensive test menus include MRSA, C.difficile (with/without epidemic strain 027), COVID-19, influenza, RSV, Chlamydia trachomatis/Neisseria gonorrhea, MTB and RIF resistance, strep group A, T.vaginalis, Carbapenemase producing organism identification, MRSA/S.aureus blood culture identification, and MVP identification. Services will be provided to Brooklyn, Castle Point, East Orange, Franklin Delano Roosevelt, James J. Peters, Margaret Cochran, and Northport VA Medical Centers. The use of gray market items is prohibited.
Contract & Timeline
- Type: Firm Fixed Price (FFP), Sole Source (intended)
- Intended Contractor: Cepheid Inc.
- Set-Aside: None (Sole Source)
- Capability Statement Due: May 22, 2026, 12:00 PM EST
- Published: May 5, 2026
Evaluation
This is a notice of intent to award a sole source contract, not a request for quotes. Market research, conducted in accordance with FAR Part 10, determined that Cepheid Inc. is the only reasonably capable source due to their ability to provide maintenance and testing supplies for existing DVA-owned equipment and comprehensive test menus. Responsible sources may submit capability statements for government consideration. A determination not to compete this proposed contract based on responses is solely at the Government's discretion.
Additional Notes
This notice satisfies the public posting requirements of FAR 6.301 for justification to limit competition. Veterans Health Administration prohibits the use of gray market items.